V. Modeling and control of the anticoagulant drug heparin

Journal of Process Control

Volumn 17, Issue 7, 2007, Pages 590-594

  McAvoy, Thomas J ^a  

^a UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING ENERGY; COMPUTER SIMULATION; MATHEMATICAL MODELS; METABOLISM; PLASMA (HUMAN); PROTEINS;

ANTICOAGULANT DRUG HEPARIN; BLOOD PLASMA; INHIBITION MECHANISM;

DRUG THERAPY;

EID: 34347215897     PISSN: 09591524     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jprocont.2007.01.017     Document Type: Article

References (6)

1. Wessler S. Current dilemmas in the clinical use of heparin. Fed. Proc. 36 (1977) 66-69
2. Wessler S. A heparin symposium. Current Ther. Res. 18 (1975) 3-5
3. Rosenberg R. Actions and interactions of antithrombin and heparin. N. Eng. J. Med. 292 (1975) 146-151
4. Rosenberg R. Chemistry of the hemostatic mechanism and its relationship to the action of heparin. Fed. Proc. 36 (1977) 10-19
5. McAvoy T.J. Pharmacokinetic modeling of heparin and its clinical implications. J. Pharm. Biopharm. 7 (1979) 331-354
6. Perrier D., Ash1ey L., and Levy G. Effect of production inhibition on kinetics of drug elimination. J. Pharm. Biopharm. 1 (1973) 231-242